FDA warns of rare cancer linked to breast implants
In a letter to doctors, nurses and other health professionals, the FDA has issued a warning concerning a rare cancer linked to breast implants. The cancer, known as breast implant-associated anaplastic large cell lymphoma, usually forms in scar tissue that forms around implants. However, it should be noted that the disease is not breast cancer. The FDA warning applies to all types of breast implants, both saline and silicone.
SILVER SPRING, Md. – U.S. medical authorities are revisiting the safety of breast implants used by millions of American women, the latest review in a multi-decade debate about their health effects.
An expert panel assembled by the Food and Drug Administration meets for two days starting Monday to discuss the latest evidence about the risks of illness and complications with the devices, which are used for cosmetic and reconstructive surgery.
MODEL HAD BREAST IMPLANTS REMOVED AFTER SHE SAYS BODY BEGAN REJECTING THEM
The FDA is grappling with a recently confirmed link between the implants and a rare form of cancer. Additionally, many women are pushing the agency to address longstanding — but unconfirmed — claims that implants can contribute to other chronic ailments.
The FDA panel will hear from researchers, plastic surgeons, patients and manufacturers.
CLICK HERE TO GET THE FOX NEWS APP
For now, the FDA isn’t proposing any new restrictions or warnings.
Be the first to comment